PHARMOPSIS
ActiveSummary
PHARMOPSIS has been active since 2008 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €626k and a net result of €5k. Equity is growing by ~11.8% per year across the filed fiscal years. Its solvency ranks better than 89% of 37953 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2024
Axes · tick = 2023
Profitability70▼-3
Solvency100=
Growth52=
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €50k at 30 days acceptable
Liquidity ample (current ratio 16.12 against 28.38 in 2023; short-term debt: 5.8% and cash: 2.8% of total assets), and 9.1% of the assets are financed with debt.
Credit check for your own amount and term
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 70
Relative position
BE, all sectors
reference
Activities of head offices; management consultancy activities (NACE 70)
about 69% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2024Solvency, return and age of the figures
Solvency
90.9%
Return on assets
0.7%
Age of the figures
21 mo
neutral · Filed after the deadline
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 30-09-2025, 61 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
not confirmed
2024
61 d late
2023
57 d late
2022
60 d late
2021
45 d late
2020
51 d late
2019
98 d late
← before the deadline
after the deadline →
Checked, nothing found (1)
Financials · fiscal year 2024, micro schema
Equity
€626k▲ 0.7%
2023 · €622k
Total assets
€689k▲ 7.2%
2023 · €643k
Net result
€5k▼ 78.4%
2023 · €21k
Working capital
€604k▲ 2.8%
2023 · €588k
Trend over the years
Click a name to add, emphasise or remove a line.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20202021202220232024
Operating result€95k▼ 51.8%€112k▲ 17.0%€142k▲ 27.0%€47k▼ 66.7%€26k▼ 45.4%
Net result€56k▼ 62.3%€68k▲ 22.8%€93k▲ 36.4%€21k▼ 77.1%€5k▼ 78.4%
Equity€455k▲ 13.9%€524k▲ 15.0%€617k▲ 17.8%€622k▲ 0.8%€626k▲ 0.7%
Total assets€631k▲ 32.7%€611k▼ 3.1%€732k▲ 19.8%€643k▼ 12.2%€689k▲ 7.2%
Debt€176k▲ 132%€88k▼ 50.1%€115k▲ 31.6%€21k▼ 81.4%€63k▲ 194%
Working capital€423k▲ 6.0%€490k▲ 16.0%€590k▲ 20.3%€588k▼ 0.3%€604k▲ 2.8%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result has fallen two years in a row; 2024 is 45% below 2023 and is the lowest result in the available series.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €689k
Fixed assets
€45k ▲ 33.8%
Current assets
€644k ▲ 5.7%
Equity and liabilities €689k
Equity
€626k ▲ 0.7%
Debt
€63k ▲ 194%
Debt's share of the balance-sheet total rises from 3.3% to 9.1%. Equity and debt are higher.
Key figures and ratios
EBITDA
€39k▼
2023 · €54k
Cash flow
€18k▼
2023 · €29k
Current ratio
16.12▼
2023 · 28.38
Debt to equity
0.10▲
2023 · 0.03
ROE
0.7%▼
2023 · 3.4%
ROA
0.7%▼
2023 · 3.3%
Interest coverage
17.33▼
2023 · 129.78
Debt ≤ 1 year
€40k▲
2023 · €21k
Debt > 1 year
€23k
Income taxes
€19k▼
2023 · €26k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €6k | €15k | €12k | €7k | €14k | ▲ 87.1% |
| Other operating charges640/8 | - | €251 | €102 | €162 | €525 | ▲ 224% |
| Gross operating margin9900 | €102k | €127k | €153k | €55k | €40k | ▼ 27.1% |
| Operating profit (loss)9901 | €95k | €112k | €142k | €47k | €26k | ▼ 45.4% |
| Financial income75/76B | - | - | €0 | €0 | €0 | ▲ 58.3% |
| Recurring financial income75 | - | - | €0 | €0 | €0 | ▲ 58.3% |
| Financial charges65/66B | - | €255 | €503 | €420 | €2k | ▲ 440% |
| Recurring financial charges65 | €433 | €255 | €503 | €420 | €2k | ▲ 440% |
| Profit (loss) for the period before taxes9903 | €95k | €111k | €141k | €47k | €24k | ▼ 49.8% |
| Income taxes67/77 | €39k | €43k | €48k | €26k | €19k | ▼ 25.9% |
| Profit (loss) for the period9904 | €56k | €68k | €93k | €21k | €5k | ▼ 78.4% |
| Profit (loss) for the period to be appropriated9905 | €56k | €68k | €93k | €21k | €5k | ▼ 78.4% |
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €631k | €611k | €732k | €643k | €689k | ▲ 7.2% |
| Fixed assets21/28 | €33k | €33k | €27k | €34k | €45k | ▲ 33.8% |
| Tangible fixed assets22/27 | €32k | €32k | €26k | €33k | €44k | ▲ 34.7% |
| Plant, machinery and equipment23 | - | €21k | €15k | €11k | €5k | ▼ 52.4% |
| Furniture and vehicles24 | - | €12k | €11k | €9k | €39k | ▲ 323% |
| Other tangible fixed assets26 | - | - | - | €13k | - | - |
| Financial fixed assets28 | €855 | €855 | €855 | €855 | €855 | = |
| Current assets29/58 | €598k | €578k | €705k | €609k | €644k | ▲ 5.7% |
| Amounts receivable within one year40/41 | €445k | €515k | €655k | €579k | €622k | ▲ 7.3% |
| Trade receivables40 | - | €104k | €145k | €57k | €75k | ▲ 30.5% |
| Other amounts receivable41 | - | €412k | €510k | €522k | €547k | ▲ 4.8% |
| Cash at bank and in hand54/58 | €149k | €58k | €50k | €24k | €19k | ▼ 20.3% |
| Deferred charges and accrued income490/1 | - | €5k | €159 | €6k | €3k | ▼ 45.3% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €631k | €611k | €732k | €643k | €689k | ▲ 7.2% |
| Equity10/15 | €455k | €524k | €617k | €622k | €626k | ▲ 0.7% |
| Contributions10/11 | - | €19k | €19k | €2k | €2k | = |
| Reserves13 | €437k | €505k | €598k | €620k | €624k | ▲ 0.7% |
| Non-distributable reserves130/1 | - | €2k | €2k | - | - | - |
| Reserves not available under the articles1311 | - | €2k | €2k | - | - | - |
| Distributable reserves133 | - | €503k | €596k | €620k | €624k | ▲ 0.7% |
| Amounts payable17/49 | €176k | €88k | €115k | €21k | €63k | ▲ 194% |
| Amounts payable after more than one year17 | - | - | - | - | €23k | - |
| Financial debts170/4 | - | - | - | - | €23k | - |
| Amounts payable within one year42/48 | €176k | €88k | €115k | €21k | €40k | ▲ 86.2% |
| Current portion of amounts payable after more than one year42 | - | - | - | - | €6k | - |
| Trade debts44 | €66k | €12k | €11k | - | - | - |
| Suppliers440/4 | - | €12k | €11k | - | - | - |
| Taxes, remuneration and social security45 | - | €76k | €58k | €19k | €13k | ▼ 29.6% |
| Taxes450/3 | - | €76k | €58k | €19k | €13k | ▼ 29.6% |
| Other amounts payable47/48 | - | - | €46k | €2k | €20k | ▲ 741% |
| Accrued charges and deferred income492/3 | - | - | - | - | €290 | - |
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €56k | €68k | €93k | €21k | €5k | ▼ 78.4% |
| + Depreciation and write-downs630 | €6k | €15k | €12k | €7k | €14k | ▲ 87.1% |
| Operating cash flow (approximation) | €62k | €84k | €105k | €29k | €18k | ▼ 36.5% |
| Investment in fixed assets (approximation) | - | €-16k | €-5k | €-14k | €-25k | ▼ 78.8% |
| Change in cash | - | €-90k | €-8k | €-26k | €-5k | ▲ 81.3% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
2025
30-09
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 61 days late
2024
31-12
Financial
Weakest financial yearnet €5k ▼78.4%
Net result drops to €5k, the lowest in the series.
26-09
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 57 days late
2023
31-12
Financial
Liquidity times 5current ratio 28.38
Current ratio from 6.11 to 28.38; short-term debt falls from €115k to €21k.
29-09
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 60 days late
2022
14-09
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 45 days late
2021
31-12
Financial
Equity above €500kEq €524k ▲15%
4 profitable years in a row build equity to €524k.
20-09
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 51 days late
2020
06-11
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema · 98 days late
2019
31-12
Financial
Highest result since 2018net €148k ▲32.7%
Operating result €198k, net result €148k, both a record.
29-08
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema · 29 days late
2018
25-09
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema · 56 days late
2017
24-08
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema · 24 days late
2016
12-08
NBB filing
Annual accounts filed
fiscal year 2015 · abbreviated schema · 12 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 3 acts read
About the unread acts
We know of 3 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Antwerpen · 1 establishment unit since 2008
Ground area
3,513 m²
Building footprint
1,136 m²
Volume, LiDAR
27,578 m³
Parcel 11802B2284/00A000, Flanders · tallest building 32.3 m, ±9 floors. Linked by address, not a title deed.
13
companies at this address
See who is registered here
1 establishment unit
PHARMOPSIS
since 20082.170.125.273
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 11802B2284/00A000 | Flanders | 3,513 m² | 1 · 1,136 m² | 32.3 m · 9 fl. |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
CS&K Projects
BE 0705.847.323
Wavre · Eq €626,172
IKARA
BE 0477.257.816
Arendonk · Eq €626,269
INVESTEA
BE 0554.946.205
Sint-Pieters-Woluwe · Eq €626,291
LEMAHIEU INVEST
BE 1012.561.026
Torhout · Eq €626,122
EduCara
BE 0776.589.423
Mortsel · Eq €626,067
Of 82,632 companies in sector 70200 we hold annual accounts for 52,575. 32,675 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded07-03-2008
Fiscal year end31-12
Activities, NACEBEL 2025
70200Business and other management consultancy
Scores and ratios are computed by Checked and are not a credit decision.